TY - JOUR
T1 - Amino acid transporters revisited
T2 - New views in health and disease
AU - Kandasamy, Palanivel
AU - Gyimesi, Gergely
AU - Kanai, Yoshikatsu
AU - Hediger, Matthias A.
N1 - Publisher Copyright:
© 2018 Elsevier Ltd
PY - 2018/10
Y1 - 2018/10
N2 - Amino acid transporters (AATs) are membrane-bound transport proteins that mediate transfer of amino acids into and out of cells or cellular organelles. AATs have diverse functional roles ranging from neurotransmission to acid-base balance, intracellular energy metabolism, and anabolic and catabolic reactions. In cancer cells and diabetes, dysregulation of AATs leads to metabolic reprogramming, which changes intracellular amino acid levels, contributing to the pathogenesis of cancer, obesity and diabetes. Indeed, the neutral amino acid transporters (NATs) SLC7A5/LAT1 and SLC1A5/ASCT2 are likely involved in several human malignancies. However, a clinical therapy that directly targets AATs has not yet been developed. The purpose of this review is to highlight the structural and functional diversity of AATs, their diverse physiological roles in different tissues and organs, their wide-ranging implications in human diseases and the emerging strategies and tools that will be necessary to target AATs therapeutically.
AB - Amino acid transporters (AATs) are membrane-bound transport proteins that mediate transfer of amino acids into and out of cells or cellular organelles. AATs have diverse functional roles ranging from neurotransmission to acid-base balance, intracellular energy metabolism, and anabolic and catabolic reactions. In cancer cells and diabetes, dysregulation of AATs leads to metabolic reprogramming, which changes intracellular amino acid levels, contributing to the pathogenesis of cancer, obesity and diabetes. Indeed, the neutral amino acid transporters (NATs) SLC7A5/LAT1 and SLC1A5/ASCT2 are likely involved in several human malignancies. However, a clinical therapy that directly targets AATs has not yet been developed. The purpose of this review is to highlight the structural and functional diversity of AATs, their diverse physiological roles in different tissues and organs, their wide-ranging implications in human diseases and the emerging strategies and tools that will be necessary to target AATs therapeutically.
KW - acid-base balance
KW - ammoniagenesis
KW - autophagy
KW - cancer
KW - diabetes mellitus
KW - energy metabolism
KW - excitotoxicity
KW - glutamine-glutamate cycle
KW - inborn errors of metabolism
KW - insulin and glucagon secretion
KW - longevity
KW - membrane protein structure
KW - membrane transport
KW - metabolic acidosis
KW - mTORC1/S6K1 pathway
KW - neurotransmission
KW - pancreas
KW - Solute carriers (SLCs)
UR - https://www.scopus.com/pages/publications/85052745851
UR - https://www.scopus.com/pages/publications/85052745851#tab=citedBy
U2 - 10.1016/j.tibs.2018.05.003
DO - 10.1016/j.tibs.2018.05.003
M3 - Review article
C2 - 30177408
AN - SCOPUS:85052745851
SN - 0968-0004
VL - 43
SP - 752
EP - 789
JO - Trends in Biochemical Sciences
JF - Trends in Biochemical Sciences
IS - 10
ER -